Virax Biolabs Group Ownership | Who Owns Virax Biolabs Group?


OverviewChart

Virax Biolabs Group Ownership Summary


Virax Biolabs Group is owned by 0.73% institutional investors, 5.46% insiders, and 93.81% retail investors. Virtu financial is the largest institutional shareholder, holding 0.69% of VRAX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Virax Biolabs Group shares.

VRAX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVirax Biolabs Group0.73%5.46%93.81%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Virtu financial21.38K0.69%$13.00K
Royal bank of canada10.40K0.52%$23.00K
National bank of canada /fi/10.00K0.32%$6.00K
Ubs group7.49K0.16%$2.59K
Northwestern mutual wealth management10.000.00%$3.00
Squarepoint ops---
Xtx topco---
Hrt financial lp---
Headlands---
Renaissance---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Virtu financial21.38K0.00%$13.00K
Renaissance---
Tower research capital llc (trc)---
Two sigma securities---
Jane street group---
Northwestern mutual wealth management10.00-$3.00
Squarepoint ops---
Ubs group7.49K-$2.59K
Xtx topco---
Hrt financial lp---

Top Buyers

HolderShares% AssetsChange
Virtu financial21.38K0.00%21.38K
Royal bank of canada10.40K-10.40K
National bank of canada /fi/10.00K-5.00K
Ubs group7.49K-4.13K
Northwestern mutual wealth management10.00-10.00

Top Sellers

HolderShares% AssetsChange
Renaissance---145.40K
Hrt financial lp---60.07K
Squarepoint ops---40.62K
Two sigma securities---13.63K
Xtx topco---11.86K

New Positions

HolderShares% AssetsChangeValue
Virtu financial21.38K0.00%21.38K$13.00K
Royal bank of canada10.40K-10.40K$23.00K
Northwestern mutual wealth management10.00-10.00$3.00

Sold Out

HolderChange
Tower research capital llc (trc)-9.00
Headlands-185.00
Jane street group-11.63K
Xtx topco-11.86K
Two sigma securities-13.63K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20254-34,939-63.15%-7.83%3-25.00%1-
Sep 30, 20254100.00%94,809169.69%3237.59%4100.00%--
Jun 30, 20252-50.00%35,155-44.29%127.34%2-33.33%--100.00%
Mar 31, 20254-42.86%63,0980.14%220.66%3-57.14%1-
Dec 31, 2024740.00%63,007-71.15%32.65%740.00%--

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index542.000.01%-

Insider Transactions Trends


DateBuySell
2026 Q1--

VRAX Ownership FAQ


Who Owns Virax Biolabs Group?

Virax Biolabs Group shareholders are primarily institutional investors at 0.73%, followed by 5.46% insiders and 93.81% retail investors. The average institutional ownership in Virax Biolabs Group's industry, Biotech Stocks , is 382.13%, which Virax Biolabs Group falls below.

Who owns the most shares of Virax Biolabs Group?

Virax Biolabs Group’s largest shareholders are Virtu financial (21.38K shares, 0.69%), Royal bank of canada (10.4K shares, 0.52%), and National bank of canada /fi/ (10K shares, 0.32%). Together, they hold 1.53% of Virax Biolabs Group’s total shares outstanding.

Does Blackrock own Virax Biolabs Group?

BlackRock is not among the top 10 institutional shareholders of Virax Biolabs Group.

Who is Virax Biolabs Group’s biggest shareholder by percentage of total assets invested?

Virtu financial is Virax Biolabs Group’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 21.38K Virax Biolabs Group shares, valued at 13K$.

Who is the top mutual fund holder of Virax Biolabs Group shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Virax Biolabs Group shares, with 0.01% of its total shares outstanding invested in 542 Virax Biolabs Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools